HLA and non-HLA genes in Behçet's disease: A multicentric study in the Spanish population

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Montes Cano, Marco A ^a   Conde Jaldón, Marta ^a   García Lozano, José R ^a   Ortiz Fernández, Lourdes ^a   Ortego Centeno, Norberto ^b   Castillo Palma, María J ^c   Espinosa, Gerard ^d   Graña Gil, Genaro ^e   González Gay, Miguel A ^f   Barnosi Marín, Ana C ^g   Solans, Roser ^h   Fanlo, Patricia ⁱ   Camps, Teresa ^j   Castañeda, Santos ^k   Sánchez Bursón, Juan ^l   Núñez Roldán, Antonio ^a   Martín, Javier ^m   González Escribano, María F ^a  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e CHU A Coruna   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g HOSPITAL TORRECÁRDENAS   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ Instituto de Investigación Sanitaria de Navarra   (Spain)

^j HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^k HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^l HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^m Lopez Neyra Institute   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A01 ANTIGEN; HLA A02 ANTIGEN; HLA A03 ANTIGEN; HLA A11 ANTIGEN; HLA A23 ANTIGEN; HLA A24 ANTIGEN; HLA A25 ANTIGEN; HLA A26 ANTIGEN; HLA A29 ANTIGEN; HLA A30 ANTIGEN; HLA A31 ANTIGEN; HLA A32 ANTIGEN; HLA A33 ANTIGEN; HLA A66 ANTIGEN; HLA A68 ANTIGEN; HLA A69 ANTIGEN; HLA A80 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN A; HLA ANTIGEN B; HLA B07 ANTIGEN; HLA B18 ANTIGEN; HLA B35 ANTIGEN; HLA B38 ANTIGEN; HLA B51 ANTIGEN; HLA B57 ANTIGEN; HLA B58 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 23; INTERLEUKIN 23R; UNCLASSIFIED DRUG; HLA A ANTIGEN; HLA B ANTIGEN; HLA-B57 ANTIGEN; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MIDDLE AGED; SPAIN; STATISTICAL MODEL;

ADULT; BEHCET SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-B35 ANTIGEN; HLA-B51 ANTIGEN; HUMANS; INTERLEUKIN-10; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RISK FACTORS; SPAIN;

EID: 84884970744     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4328     Document Type: Article

References (38)

1. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J. Behçet's disease-a contemporary review. J Autoimmun 2009, 32:178-188. 10.1016/j.jaut.2009.02.011, 19324519.
2. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou I. Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. J Pediatr 1999, 135:89-93. 10.1016/S0022-3476(99)70333-1, 10393610.
3. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999, 341:1284-1291. 10.1056/NEJM199910213411707, 10528040.
4. de Menthon M, LaValley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009, 61:1287-1296. 10.1002/art.24642, 19790126.
5. Itoh Y, Inoko H, Kulski JK, Sasaki S, Meguro A, Takiyama N, Nishida T, Yuasa T, Ohno S, Mizuki N. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behçet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006, 67:390-394. 10.1111/j.1399-0039.2006.00586.x, 16671946.
6. Choukri F, Chakib A, Himmich H, Hüe S, Caillat-Zucman S. HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients. Hum Immunol 2001, 62:180-185. 10.1016/S0198-8859(00)00249-4, 11182229.
7. Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP. Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?. Arthritis Rheum 2003, 48:807-813. 10.1002/art.10815, 12632436.
8. Gül A, Uyar FA, Inanç M, Ocal L, Barrett JH, Aral O, Koniçe M, Saruhan-Direskeneli G. A weak association of HLA-B*2702 with Behçet's disease. Genes Immun 2002, 3:368-372. 10.1038/sj.gene.6363863, 12209364.
9. Bettencourt A, Pereira C, Carvalho L, Carvalho C, Patto JV, Bastos M, Silva AM, Barros R, Vasconcelos C, Paiva P, Costa L, Costa PP, Mendonça D, Correia J, Silva BM. New insights of HLA class I association to Behçet's disease in Portuguese patients. Tissue Antigens 2008, 72:379-382. 10.1111/j.1399-0039.2008.01087.x, 18627572.
10. Radouane A, Oudghiri M, Chakib A, Naya A, Belhouari A, El Malki A, Bennani S. HLA-B*27 allele associated to Behçet's disease and to anterior uveitis in Moroccan patients. Ann Biol Clin (Paris) 2011, 69:419-424.
11. Arber N, Klein T, Meiner Z, Pras E, Weinberger A. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis 1991, 50:351-353. 10.1136/ard.50.6.351, 1004434, 2059078.
12. Soto-Vega E, García-Muñoz R, Richaud-Patin Y, Zúñiga-Ramos J, Crispín JC, Díaz-Jouanen E, Flores-Suárez LF, Llorente L, Granados J. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. Immunol Lett 2004, 93:211-215. 10.1016/j.imlet.2004.03.017, 15158619.
13. Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Casali B, Kötter I, Gutierrez-Achury J, Wijmenga C, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013, 45:319-324. 10.1038/ng.2551, 23396137.
14. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007, 3:148-155. 10.1038/ncprheum0436, 17334337.
15. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982, 100:1455-1458. 10.1001/archopht.1982.01030040433013, 6956266.
16. Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, Yamakawa R, Yuasa T, Fujioka T, Ohno S, Bahram S, Mizuki N. Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis 2010, 69:747-754. 10.1136/ard.2009.108571, 19684014.
17. Karasneh J, Gül A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 2005, 52:1836-1842. 10.1002/art.21060, 15934084.
18. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study. Arthritis Res Ther 2009, 11:R66. 10.1186/ar2695, 2714112, 19442274.
19. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010, 42:698-702. 10.1038/ng.625, 2923807, 20622878.
20. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010, 42:703-706. 10.1038/ng.624, 20622879.
21. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080. International Study Group for Behçet's Disease.
22. Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. IL-23R gene confers susceptibility to Behçet's disease in a Chinese Han population. Ann Rheum Dis 2010, 69:1325-1328. 10.1136/ard.2009.119420, 20375120.
23. International HapMap Project HapMap DataRel 24 database http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap24_B36/, International HapMap Project.
24. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994, 43:18-27. 10.1111/j.1399-0039.1994.tb02291.x, 8023317.
25. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69:138-147. 10.1086/321276, 1226028, 11404819.
26. Moore JH. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 2004, 4:795-803. 10.1586/14737159.4.6.795, 15525222.
27. Computational Genetics Laboratory, Institute for Quantitative Biomedical Sciences, Geisel School of Medicine and Dartmouth College Multifactor Dimensionality Reduction (MDR) version 2 open-source software package http://www.multifactordimensionalityreduction.org/, Computational Genetics Laboratory, Institute for Quantitative Biomedical Sciences, Geisel School of Medicine and Dartmouth College.
28. Kera J, Mizuki N, Ota M, Katsuyama Y, Pivetti-Pezzi P, Ohno S, Inoko H. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 1999, 54:565-571. 10.1034/j.1399-0039.1999.540605.x, 10674970.
29. Sanjanwala B, Draghi M, Norman PJ, Guethlein LA, Parham P. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J Immunol 2008, 181:6293-6300. 2634290, 18941220.
30. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) IMGT/HLA Sequence Alignment Tool http://www.ebi.ac.uk/imgt/hla/align.html, European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI).
31. Mizuki N, Ohno S, Ando H, Chen L, Palimeris GD, Stavropoulos-Ghiokas E, Ishihara M, Goto K, Nakamura S, Shindo Y, Isobe K, Ito N, Inoko H. A strong association between HLA-Bz.ast;5101 and Behçet's disease in Greek patients. Tissue Antigens 1997, 50:57-60. 10.1111/j.1399-0039.1997.tb02835.x, 9243757.
32. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799. 10.1038/35869, 9486650.
33. Ota M, Mizuki N, Katsuyama Y, Tamiya G, Shiina T, Oka A, Ando H, Kimura M, Goto K, Ohno S, Inoko H. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 1999, 64:1406-1410. 10.1086/302364, 1377878, 10205273.
34. de Bakker PI, Raychaudhuri S. Interrogating the major histocompatibility complex with high-throughput genomics. Hum Mol Genet 2012, 21(R1):R29-R36. 10.1093/hmg/dds384, 3459647, 22976473.
35. Xavier JM, Shahram F, Davatchi F, Rosa A, Crespo J, Abdollahi BS, Nadji A, Jesus G, Barcelos F, Patto JV, Shafiee NM, Ghaderibarim F, Oliveira SA. Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behçet's disease. Arthritis Rheum 2012, 64:2761-2772. 10.1002/art.34437, 22378604.
36. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753. 10.1136/gut.2009.199679, 21300624.
37. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH, Mathew CG, Schreiber S, the IBSEN study group Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323. 10.1038/ng.221, 18836448, the IBSEN study group.
38. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Rantapää-Dahlqvist S, Baechler EC, Brown EE, Alarcón GS, Edberg JC, Ramsey-Goldman R, McGwin G, Reveille JD, Vilá LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233. 10.1038/ng.468, 2925843, 19838195.